Blood Cancer Journal · 2015 · 57 citations · 28 references
MedicineMedicinal ChemistryPharmacologyChemotherapyDrug DiscoveryMolecular PharmacologyDrug DatabasesOncology PharmacologyPreclinical Drug EvaluationStructure-activity Relationship Analysis60S Ribosomal Subunit BiogenesisAcute LeukemiasAcute Myeloid Leukemia BiologyAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentDrug Reference DatabasesRna Polymerase I ActivityRna Polymerase I Function
To find drugs suitable for repositioning for use against leukemia, samples from patients with chronic lymphocytic, acute myeloid and lymphocytic leukemias as well as peripheral blood mononuclear cells (PBMC) were tested in response to 1266 compounds from the LOPAC(1280) library (Sigma). Twenty-five compounds were defined as hits with activity in all leukemia subgroups (<50% cell survival compared with control) at 10 μM drug concentration. Only one of these compounds, quinacrine, showed low activity in normal PBMCs and was therefore selected for further preclinical evaluation. Mining the NCI-60 and the NextBio databases demonstrated leukemia sensitivity and the ability of quinacrine to reverse myeloid leukemia gene expression. Mechanistic exploration was performed using the NextBio bioinformatic software using gene expression analysis of drug exposed acute myeloid leukemia cultures (HL-60) in the database. Analysis of gene enrichment and drug correlations revealed strong connections to ribosomal biogenesis nucleoli and translation initiation. The highest drug-drug correlation was to ellipticine, a known RNA polymerase I inhibitor. These results were validated by additional gene expression analysis performed in-house. Quinacrine induced early inhibition of protein synthesis supporting these predictions. The results suggest that quinacrine have repositioning potential for treatment of acute myeloid leukemia by targeting of ribosomal biogenesis.
28
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
Mark J. Levis, Jeffrey Allebach, Kam-Fai Tse et al. · Blood · 2002 · 474 citations
Medicine, Oncology, Pharmacology +11
Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data
Ilya Kupershmidt, Qiaojuan Jane Su, Anoop Grewal et al. · PLoS ONE · 2010 · 373 citations · Full text